Cargando…
PB1768: IS NATIVE E-COLI OR PEG-ASPERAGINASE FORMULATION A HIGHER RISK FOR VTE DEVELOPMENT IN PATIENTS WITH POST TREATMENT ACUTE LYMPHOBLASTIC LEUKEMIA? A META-ANALYSIS
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429150/ http://dx.doi.org/10.1097/01.HS9.0000849928.29244.22 |
| _version_ | 1784779347358384128 |
|---|---|
| author | Seki, J. T. Atenafu, E. Sibai, H. |
| author_facet | Seki, J. T. Atenafu, E. Sibai, H. |
| author_sort | Seki, J. T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429150 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94291502022-08-31 PB1768: IS NATIVE E-COLI OR PEG-ASPERAGINASE FORMULATION A HIGHER RISK FOR VTE DEVELOPMENT IN PATIENTS WITH POST TREATMENT ACUTE LYMPHOBLASTIC LEUKEMIA? A META-ANALYSIS Seki, J. T. Atenafu, E. Sibai, H. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429150/ http://dx.doi.org/10.1097/01.HS9.0000849928.29244.22 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Seki, J. T. Atenafu, E. Sibai, H. PB1768: IS NATIVE E-COLI OR PEG-ASPERAGINASE FORMULATION A HIGHER RISK FOR VTE DEVELOPMENT IN PATIENTS WITH POST TREATMENT ACUTE LYMPHOBLASTIC LEUKEMIA? A META-ANALYSIS |
| title | PB1768: IS NATIVE E-COLI OR PEG-ASPERAGINASE FORMULATION A HIGHER RISK FOR VTE DEVELOPMENT IN PATIENTS WITH POST TREATMENT ACUTE LYMPHOBLASTIC LEUKEMIA? A META-ANALYSIS |
| title_full | PB1768: IS NATIVE E-COLI OR PEG-ASPERAGINASE FORMULATION A HIGHER RISK FOR VTE DEVELOPMENT IN PATIENTS WITH POST TREATMENT ACUTE LYMPHOBLASTIC LEUKEMIA? A META-ANALYSIS |
| title_fullStr | PB1768: IS NATIVE E-COLI OR PEG-ASPERAGINASE FORMULATION A HIGHER RISK FOR VTE DEVELOPMENT IN PATIENTS WITH POST TREATMENT ACUTE LYMPHOBLASTIC LEUKEMIA? A META-ANALYSIS |
| title_full_unstemmed | PB1768: IS NATIVE E-COLI OR PEG-ASPERAGINASE FORMULATION A HIGHER RISK FOR VTE DEVELOPMENT IN PATIENTS WITH POST TREATMENT ACUTE LYMPHOBLASTIC LEUKEMIA? A META-ANALYSIS |
| title_short | PB1768: IS NATIVE E-COLI OR PEG-ASPERAGINASE FORMULATION A HIGHER RISK FOR VTE DEVELOPMENT IN PATIENTS WITH POST TREATMENT ACUTE LYMPHOBLASTIC LEUKEMIA? A META-ANALYSIS |
| title_sort | pb1768: is native e-coli or peg-asperaginase formulation a higher risk for vte development in patients with post treatment acute lymphoblastic leukemia? a meta-analysis |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429150/ http://dx.doi.org/10.1097/01.HS9.0000849928.29244.22 |
| work_keys_str_mv | AT sekijt pb1768isnativeecoliorpegasperaginaseformulationahigherriskforvtedevelopmentinpatientswithposttreatmentacutelymphoblasticleukemiaametaanalysis AT atenafue pb1768isnativeecoliorpegasperaginaseformulationahigherriskforvtedevelopmentinpatientswithposttreatmentacutelymphoblasticleukemiaametaanalysis AT sibaih pb1768isnativeecoliorpegasperaginaseformulationahigherriskforvtedevelopmentinpatientswithposttreatmentacutelymphoblasticleukemiaametaanalysis |